{"result": {"id": "0079eef7-1d91-474d-8870-142e06135555", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CYP3A4<|>ORGANIZATION<|>CYP3A4 is an enzyme that can interfere with chemotherapy drug metabolism, increasing the risk of toxicity\")\n##\n(\"entity\"<|>VEGFi<|>ORGANIZATION<|>VEGFi is a treatment that can reduce nitric oxide generation and is used in managing hypertension during tumor treatment\")\n##\n(\"entity\"<|>DM<|>ORGANIZATION<|>DM stands for diabetes, a chronic condition mentioned in the context of hypertension management\")\n##\n(\"entity\"<|>CKD<|>ORGANIZATION<|>CKD stands for chronic kidney disease, a condition mentioned in the context of hypertension management\")\n##\n(\"entity\"<|>CVD<|>ORGANIZATION<|>CVD stands for cardiovascular disease, a condition mentioned in the context of hypertension management\")\n##\n(\"entity\"<|>MDT<|>ORGANIZATION<|>MDT stands for multidisciplinary consultation, used in managing hypertension during tumor treatment\")\n##\n(\"entity\"<|>COPD<|>ORGANIZATION<|>COPD stands for chronic obstructive pulmonary disease, a condition often coexisting with hypertension\")\n##\n(\"relationship\"<|>CYP3A4<|>VEGFi<|>Both CYP3A4 and VEGFi are involved in the management of hypertension during tumor treatment<|>3)\n##\n(\"relationship\"<|>DM<|>CKD<|>Both DM and CKD are chronic conditions mentioned in the context of hypertension management<|>2)\n##\n(\"relationship\"<|>CKD<|>CVD<|>Both CKD and CVD are chronic conditions mentioned in the context of hypertension management<|>2)\n##\n(\"relationship\"<|>DM<|>CVD<|>Both DM and CVD are chronic conditions mentioned in the context of hypertension management<|>2)\n##\n(\"relationship\"<|>COPD<|>DM<|>COPD and DM are both chronic conditions that can coexist with hypertension<|>2)\n##\n(\"relationship\"<|>COPD<|>CKD<|>COPD and CKD are both chronic conditions that can coexist with hypertension<|>2)\n##\n(\"relationship\"<|>COPD<|>CVD<|>COPD and CVD are both chronic conditions that can coexist with hypertension<|>2)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558747, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 517, "prompt_tokens": 2402, "total_tokens": 2919, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 610}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 维拉帕米) , 因其可通过抑制 CYP3A4干  扰化疗药物代谢增加化疗毒性的风险 。应用利尿剂时  需警惕因化疗引起的恶心和呕吐或脱水导致急性肾损  伤[638] 。对顽固性高血压可应用螺内酯[403] 、口服或硝  酸酯皮贴(VEGFi减少一氧化氮生成)[635,639] 。有高交  感神经张力、压力和/或疼痛的肿瘤患者 , 推荐应用  β受体阻滞剂 。对于存在液体潴留的患者 ,推荐应用  利尿剂 ,首选螺内酯 ,但应监测电解质和肾功能 。肿瘤  治疗期间高血压管理流程见图 7。\n　　　当收缩压 ≥180mmHg或舒张压 ≥110mmHg 时应通过多学科会诊评估肿瘤和心血管风险 ,并推迟  与血压增高有关的抗肿瘤治疗 ,直到血压降至<160/ 100mmHg。此外 ,患者不接受 VEGFi治疗间歇期可  能发生低血压 ,需要调整用药方案 ,完成化疗方案后需  要重新进行血压水平的评估 ,根据血压水平调整降压  方案。\n　\n　　注 :DM 为糖尿病;CKD为慢性肾脏病;CVD为心血管疾病; MDT 为多学科会诊。\n图 7  肿瘤治疗期间高血压管理流程\n\n\n8.11   高血压合并慢性阻塞性肺疾病(COPD)\n\n要点 8K   高血压合并慢性阻塞性肺疾病(COPD)\n　　　·高血压患者如果有长期吸烟史或慢性咳嗽、咳 痰及活动后气短等症状 ,应推荐肺功能检查以尽早发 现和诊断 COPD( Ⅰ ,A) 。\n　　　·高血压合并 COPD 时 ,两者的治疗均无需调 整 ;如果病情需要 , 可以使用选择性 β1  受体阻滞剂 ( Ⅰ ,A) 。\n\n　　　高 血 压 和 COPD 均 属 于 常 见 慢 性 疾 病 。 在  COPD患者中 , 40% ~ 50%的患者合 并 高 血 压[640] 。 COPD气流阻塞的程度越重 ,合并高血压、糖尿病或心  血管疾病等慢性疾病的风险以及慢性疾病相关的全因  住院和死亡风险也越高[641] 。 由于多种慢性疾病共存  的情况普遍存在 ,需要将包括高血压和 COPD在内的  多种慢性疾病一起纳入患者的慢性疾病管理[640] 。\n　　　为了早期发现和诊断 COPD患者 ,对于有长期吸  烟等危险因素 ,伴或不伴有慢性咳嗽、咳痰或活动后气  短等症状的高危人群 ,应推荐肺功能检查 。肺通气功  能测定是 COPD 的重要诊断方法 。 吸入支气管舒张  剂后的第 1 秒用力呼气容积(forced exp\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_69ed11925966bab2fa987fd1bf008eb99c849fadbdb42935ddf1e1f9fdeed7af_v2"}